ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000232712.2	Avagacestat	Bladder urothelial carcinoma	0.037611684	Resistant
ENSG00000232712.2	Avagacestat	Head and neck squamous cell carcinoma	0.009726429	Resistant